20 LATEST RESOURCES (84 INDEXED)
Psychiatric Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Pharmacovigilance Analysis of Individual Case Safety Reports Submitted to the Eudravigilance Database · January 2024
Articles
International Journal of Clinical Pharmacy
Plasma Concentrations of SSRI/SNRI After Bariatric Surgery and the Effects on Depressive Symptoms · April 2023
Articles
Frontiers in Psychiatry
Socioeconomic Status and Use of Obesogenic and Anti-Obesity Medications in the United States: A Population-Based Study · April 2022
Articles
Lancet Regional Health-Americas
Diet, Physical Activity, and Obesity among ART-Experienced People with HIV in South Africa · December 2021
Articles
AIDS Care: Psychological and Socio-Medical Aspects of AIDS/HIV
Serum Concentrations of Antidepressants, Antipsychotics, and Antiepileptics Over the Bariatric Surgery Procedure · July 2021
Articles
European Journal of Clinical Pharmacology
Intersection between Obesity, Dietary Selenium, and Statin Therapy in Brazil · June 2021
Articles
Nutrients
Association between Obesity and Neurocognitive Function in Survivors of Childhood Acute Lymphoblastic Leukemia Treated Only with Chemotherapy · April 2021
Articles (Manuscripts-Versions)
PubMed Central>Cancer
Psychiatric Safety and Weight Loss Efficacy of Naltrexone/Bupropion as Add-On to Antidepressant Therapy in Patients with Obesity or Overweight · April 2021
Articles
Journal of Affective Disorders
Energy Intake as a Short‐Term Biomarker for Weight Loss in Adults with Obesity Receiving Liraglutide: A Randomized Trial · February 2021
Articles
Obesity Science and Practice
The Association between Combined Oral Contraceptive Use and Overweight/Obesity: A Secondary Data Analysis of the 2016 Ethiopia Demographic and Health Survey · December 2020
Articles
BMJ Open
Naltrexone + Bupropion Combination for the Treatment of Binge-Eating Disorder with Obesity: A Randomized, Controlled Pilot Study · November 2020
Articles (Manuscripts-Versions)
PubMed Central>Clinical Therapeutics
Risperidone-Induced Obesity in Children and Adolescents with Autism Spectrum Disorder: Genetic and Clinical Risk Factors · November 2020
Articles
Frontiers in Pharmacology
Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People with Serious Mental Illness · October 2020
Articles
Frontiers in Endocrinology
Mediterranean Diet and Naltrexone/Bupropion Treatment for Weight Loss in Overweight and Obese Breast Cancer Survivors and Non-Cancer Participants: A Pilot Randomized Controlled Trial · September 2020
Articles
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Elucidating the Mechanisms by Which Disulfiram Protects Against Obesity and Metabolic Syndrome · July 2020
Articles
NPJ Aging and Mechanisms of Disease
Switching from Clozapine to Paliperidone Palmitate-3-Monthly Improved Obesity, Hyperglycemia and Dyslipidemia Lowering Antipsychotic Dose Equivalents in a Treatment-Resistant Schizophrenia Cohort · May 2020
Abstracts
International Clinical Psychopharmacology
Effect of an Intervention for Obesity and Depression on Patient-Centered Outcomes: An RCT · February 2020
Articles (Manuscripts-Versions)
PubMed Central>American Journal of Preventive Medicine
Naltrexone-Bupropion (Mysimba) in Management of Obesity: A Systematic Review and Meta-Analysis of Unpublished Clinical Study Reports · February 2020
Articles
NCBI>British Journal of Clinical Pharmacology
Physical Exercise and Metformin in Gestational Obesity and Prevention on Gestational Diabetes Mellitus: A Systematic Review · January 2020
Articles
Revista Brasileira de Saude Materno Infantil